Comparative Efficacy of Deferiprone, Deferoxamine and Combination of Deferiprone and Deferoxamine on Serum Ferritin Value in Beta-Thalassemia Patients 

Journal Title: Journal of Krishna Institute of Medical Sciences University - Year 2015, Vol 4, Issue 1

Abstract

Background: Iron overload is a predictable and lifethreatening complication in patients with thalassemia. Effective and convenient iron chelation remains one of the main targets of clinical management of thalassemia major. The development of a safe and effective chelator has been the goal for many years. Aims and Objective: It was aimed to compare the effect of deferiprone, deferoxamine and combination of deferiprone and deferoxamine on serum ferritin value in betathalassemia patients. Material and Methods: This controlled clinical trial was conducted on 46 major beta-thalassemic patients. Fifteen patients in deferiprone group received deferiprone 75mg/kg/day three times a day orally. Nineteen patients in deferoxamine group received deferoxamine 30-50 mg/kg/day subcutaneously for 8-12 hours/day and 5 days per week. Twelve patients in combined therapy group received deferiprone 75 mg/kg/day three times a day orally with deferoxamine 30–50 mg/kg subcutaneously every other day. Serum ferritin value was th th measured at the beginning and at the end of 6 and 12 months of study. Results: The mean of serum ferritin value in deferiprone group insignificantly increased from 2731± 1398.5 μg/L at the beginning to 2788.5 ± th 978.6 μg/L and to 3331.8 ± 1833.9 μg/L at the end of 6 th and 12 months of study, respectively. The mean of serum ferritin value in deferoxamine group insignificantly increased from 2883.5 ± 1598.1 μg/L at the th beginning to 2935.3 ± 1258.2 μg/L at the end of 6 month of study and decreased to 2773.8 ± 1216.1 μg/L th and 12 month of study. The mean of serum ferritin level in combined therapy group significantly decreased from 7498.7 ± 3512.9 μg/L at the beginning to 4839.9 ± 2698.2 μg/L (P < 0.001) and to 4298.2 ± th th 2288.7 μg/L (P < 0.001) at the end of 6 and 12 months of study, respectively. Conclusion: Combined therapy significantly decreases serum ferritin level. Study suggests deferiprone as a significant addition to support therapy in patients with betathalassemia major on regular transfusion regimens.

Authors and Affiliations

Nargesbeygom Mirbehbahani , Azam Jahazi , Haniye Mohsenkhah Amlashi , Naser Behnampour

Keywords

Related Articles

 Assessment of Knee Joint Proprioception in Weight Bearing and in Non-Weight Bearing Positions in Normal Subjects

Background: Assessment of proprioception isvaluable for identifying proprioceptive deficits.There are several methods to assess the proprioception.Joint position sense can be assessedin weight bearing (WB) and non weight...

Study of Percutaneous Coronary Intervention in Patient with Coronary Artery Disease at Tertiary Care Teaching Hospital  

Background: The interventional treatment option for the coronary artery disease has recently gained popularity. This study was intended to elaborate Percutaneous Coronary Intervention (PCI) and coronary angiographic...

A Rare Anterior Abdominal Wall Defect: Omphalocele - A Case Report 

Two most common anterior abdominal wall defects are gastroschisis and omphalocoele or exomphalos. Gastroschisis means 'stomach cleft' which is a congenital defect of the abdominal wall, usually to the right of the um...

Effect of Crude and Decaffeinated Extracts of Cola nitida Seeds on Male Reproductive System in Swiss Albino Rats

 Background: Caffeine is present in kola nut and xanthine stimulants which are used as a psychoactive drug. Therefore, the effect of kola nut (Cola nitida) extract was carried out on male reproductive system in male...

Potential Association of Hypothyroidism and Cardiovascular Disorders among Type II Diabetes Mellitus Patients Visiting for Dental Treatment

Background: Diabetes is a group of etiologically different metabolic defects characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Aim and Objectives: The study intended to...

Download PDF file
  • EP ID EP100149
  • DOI -
  • Views 80
  • Downloads 0

How To Cite

Nargesbeygom Mirbehbahani, Azam Jahazi, Haniye Mohsenkhah Amlashi, Naser Behnampour (2015). Comparative Efficacy of Deferiprone, Deferoxamine and Combination of Deferiprone and Deferoxamine on Serum Ferritin Value in Beta-Thalassemia Patients . Journal of Krishna Institute of Medical Sciences University, 4(1), 70-76. https://europub.co.uk/articles/-A-100149